Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omar Ragab

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|October 1, 2004
Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitorsMario Sechi, Massimiliano Derudas, Roberto Dallocchio, et al.
Radiation Oncology (London, England)|June 30, 2021
Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgeryHeather Miller, Koji Matsuo, Lynda D Roman, et al.
Medical Physics|January 26, 2022
Automatic segmentation of high-risk clinical target volume for tandem-and-ovoids brachytherapy patients using an asymmetric dual-path convolutional neural networkYufeng Cao, April Vassantachart, Omar Ragab, et al.
Chinese Clinical Oncology|March 12, 2020
Multidisciplinary sarcoma tumor board: retroperitoneal liposarcomaWilliam W Tseng, Jun Chen, Dakshesh Patel, et al.
Journal for Immunotherapy of Cancer|May 11, 2022
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinomaGino Kim In, Aparna Nallagangula, Jacob Seung Choi, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2020
PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern CaliforniaGino K In, Poorva Vaidya, Alexandra Filkins, et al.
Gynecologic Oncology|October 16, 2021
Corrigendum to "Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis" [Gynecologic Oncology 162 (2021) 532-538]Kimberly Levinson, Anna L Beavis, Christopher Purdy, et al.
Gynecologic Oncology|July 4, 2021
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysisKimberly Levinson, Anna L Beavis, Christopher Purdy, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Medicinal Chemistry|October 1, 2004
Design and synthesis of novel indole beta-diketo acid derivatives as HIV-1 integrase inhibitorsMario Sechi, Massimiliano Derudas, Roberto Dallocchio, et al.
Radiation Oncology (London, England)|June 30, 2021
Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: a retrospective comparison of complications for open versus minimally invasive surgeryHeather Miller, Koji Matsuo, Lynda D Roman, et al.
Medical Physics|January 26, 2022
Automatic segmentation of high-risk clinical target volume for tandem-and-ovoids brachytherapy patients using an asymmetric dual-path convolutional neural networkYufeng Cao, April Vassantachart, Omar Ragab, et al.
Chinese Clinical Oncology|March 12, 2020
Multidisciplinary sarcoma tumor board: retroperitoneal liposarcomaWilliam W Tseng, Jun Chen, Dakshesh Patel, et al.
Journal for Immunotherapy of Cancer|May 11, 2022
Clinical activity of PD-1 inhibition in the treatment of locally advanced or metastatic basal cell carcinomaGino Kim In, Aparna Nallagangula, Jacob Seung Choi, et al.
Journal of Cancer Research and Clinical Oncology|November 19, 2020
PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern CaliforniaGino K In, Poorva Vaidya, Alexandra Filkins, et al.
Gynecologic Oncology|October 16, 2021
Corrigendum to "Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis" [Gynecologic Oncology 162 (2021) 532-538]Kimberly Levinson, Anna L Beavis, Christopher Purdy, et al.
Gynecologic Oncology|July 4, 2021
Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysisKimberly Levinson, Anna L Beavis, Christopher Purdy, et al.
Pageof 3